A multicentre study to optimize echinocandin susceptibility testing of Aspergillus species with the EUCAST methodology and a broth microdilution colorimetric method by Meletiadis, J. (Joseph) et al.
A multicentre study to optimize echinocandin susceptibility testing
of Aspergillus species with the EUCAST methodology and a broth
microdilution colorimetric method
Joseph Meletiadis 1,2*, Maria Siopi1, Lamprini Kanioura2, Karin Meinike Jørgensen3, David S. Perlin4,
Johan W. Mouton2† and Maiken Cavling Arendrup 3,5,6
1
Clinical Microbiology Laboratory, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens,
Athens, Greece;
2
Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The
Netherlands;
3
Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark;
4
Center for Discovery and Innovation, Hackensack
Meridian Health, Nutley, NJ, USA;
5
Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark;
6
Department of Clinical
Medicine, University of Copenhagen, Copenhagen, Denmark
*Corresponding author. E-mail: jmeletiadis@med.uoa.gr
†Deceased.
Received 19 January 2020; returned 10 February 2020; revised 20 February 2020; accepted 26 February 2020
Background: The determination of the minimal effective concentration (MEC) of echinocandins against
Aspergillus species is subjective, time consuming and has been associated with very major errors.
Methods: The MECs/MICs of 40 WT [10 each of Aspergillus fumigatus species complex (SC), Aspergillus flavus SC,
Aspergillus terreus SC and Aspergillus niger SC] and 4 non-WT A. fumigatus isolates were determined with
EUCAST E.Def 9.3.1 read microscopically, macroscopically, spectrophotometrically and colorimetrically in three
centres. The optimal conditions for spectrophotometric (single- versus multi-point readings) and colorimetric
(XTT/menadione concentration and stability, incubation time) methods were evaluated in preliminary studies
using different cut-offs for the determination of macroscopic, spectrophotometric and colorimetric MIC end-
points compared with the microscopically determined MEC. Inter-centre and inter-method essential (within one
2-fold dilution) agreement (EA) and categorical agreement (CA) were determined.
Results: Both macroscopic and spectrophotometric endpoint readings showed poor inter-centre EA (53%–66%)
and low CA (41%–88%) in distinguishing WT from non-WT A. fumigatus SC isolates, while significant differences
compared with the microscopic MECs were observed for all echinocandins (EA 6%–54%). For the colorimetric
method, the optimal conditions were 400 mg/L XTT/6.25lM menadione, incubation for 1–2 h until the drug-free
control reached an absorbance at 450/630 nm of >0.8 and use of 50% inhibition of XTT conversion as a cut-off
for all species and echinocandins. All non-WT isolates had high XTT MICs >1 mg/L, whereas the overall inter-
centre EA and CA were 72%–89% and 100%, respectively.
Conclusions: The XTT colorimetric assay improved the antifungal susceptibility testing of echinocandins against
Aspergillus spp., reliably detecting non-WT isolates.
Introduction
Echinocandins target the fungal cell wall by blocking the synthesis
of b-(1,3)-D-glucan. They are fungicidal against Candida, but
fungistatic and less efficacious compared with amphotericin B and
voriconazole against Aspergillus infections. However, caspofungin
or micafungin are indicated in therapy-refractory or -intolerant
patients with invasive aspergillosis and in combination with other
systemic antifungal agents in settings where azole resistance is
prevalent or suspected.1,2 With increasing azole resistance
in Aspergillus fumigatus reported globally, the growing use of
echinocandins may result in emerging echinocandin resistance.
Indeed, Aspergillus spp. isolates with reduced susceptibility to
echinocandins as well as breakthrough infections emerging during
echinocandin treatment of aspergillosis have been reported,3–11
highlighting the need for reliable in vitro susceptibility testing in the
routine clinical laboratory.
Broth microdilution (BMD) methods, standardized by CLSI and
EUCAST, are considered the gold standard for evaluating
the in vitro antifungal susceptibility of moulds.12,13 The recom-
mended endpoint for determining echinocandin activity against
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filamentous fungi is the minimal effective concentration (MEC),
defined as the lowest drug concentration with aberrant growth as
a result of altered multibranched rosette morphology of mycelia.
However, this reading is not only labour intensive but also subject-
ive, which even for trained staff members may be difficult to
perform in a reproducible manner.7 Hence, the current reference
methodology is not easily incorporated into daily laboratory
practice and reduced susceptibility to echinocandins may be
underdiagnosed. Furthermore, great concern has arisen since vari-
ation has been observed in published distributions of echinocandin
MECs of Aspergillus spp.14–16 that may impede the accurate identi-
fication of non-WT isolates.7
At the same time, colorimetric readings using multiple reading
points per well and employing the dye MTT have been used to
quantify fungal growth after exposure to caspofungin and an
MIC endpoint close to the CLSI MEC was determined.17 Moreover,
colorimetric MIC endpoints were further optimized for amphoteri-
cin B, azole18 and caspofungin19 susceptibility testing of different
Aspergillus spp. using a colorimetric assay based on the water-
soluble tetrazolium salt XTT. XTT is used to assess cell viability as
actively respiring cells convert the water-soluble XTT to a water-
soluble, orange-coloured formazan product, which facilitates
automated MIC reading and provides reproducible quantitative
results. Similar methods for all three echinocandins in accordance
with the EUCAST recommendations have not yet been described,
whereas multicentre evaluation of the above-mentioned CLSI-
based methods has not been performed.
The aim of this multicentre study was to develop and validate a
reproducible EUCAST method for echinocandin susceptibility test-
ing of Aspergillus spp. that reliably differentiates WT and non-WT
isolates. For this purpose, a spectrophotometric method assessing
fungal biomass and a colorimetric method assessing metabolic
activity (MA) and viability were evaluated.
Materials and methods
Isolates
A total of 40 WT clinical isolates of Aspergillus spp. [10 each of A. fumigatus
species complex (SC), Aspergillus flavus SC, Aspergillus terreus SC and
Aspergillus niger SC] retrieved from the strain collection of Centre 1 and 4
non-WT A. fumigatus isolates from D. Perlin’s laboratory (DPL) collection
possessing elevated MEC values, with (DPL1035-homo20 and DPL240533)
or without (DPL55985 and DPL32458) known fks alterations, were tested.
Species identification of WT strains was based on the morphological
characteristics of the colonies and microscopy. Candida krusei ATCC 6258
and Candida parapsilosis ATCC 22019 were used as quality control strains.
The isolates were stored in normal sterile saline with 10% glycerol at#70C
until use.
Antifungal drugs, chemical reagents and medium
Laboratory-grade standard powders of anidulafungin (Pfizer, Inc., Groton,
CT, USA), caspofungin acetate (Merck & Co., Inc., Whitehouse, NJ, USA) and
micafungin (Astellas Pharma, Inc., Tokyo, Japan) were dissolved in DMSO
(Chem-Lab NV, Zedelgem, Belgium) and stock solutions of 10 mg/mL were
stored in small portions at#70C. XTT sodium salt (AppliChem, Darmstadt,
Germany) was dissolved in sterile water before use. Menadione (MEN;
Sigma–Aldrich, Steinheim, Germany) was dissolved in absolute ethanol
(VWR Chemicals, Fontenay-sous-Bois, France) and stock solutions of
58%10#3 M were stored at#70C. The medium used throughout was RPMI
1640 medium (with L-glutamine, without bicarbonate) (AppliChem,
Darmstadt, Germany) buffered to pH 7.0 with 0.165 M MOPS (AppliChem,
Darmstadt, Germany) and supplemented with 2% glucose (AppliChem,
Darmstadt, Germany).
BMD susceptibility testing
The reference BMD procedure was performed according to the EUCAST
guidelines.13 Briefly, each isolate was revived by subculturing it twice on
Sabouraud dextrose agar plates with gentamicin and chloramphenicol
(SGC2; bioMe´rieux) at 30C for 5–7 days and conidial suspensions were
prepared in sterile water with 0.1% Tween 20. Two-fold serial drug concen-
trations ranging from 0.001 to 1 mg/L anidulafungin and micafungin and
0.004 to 4 mg/L caspofungin (for the non-WT A. fumigatus isolates, 0.5 to
64 mg/L for all three echinocandins) were used. The plates were incubated
at 37C for up to 48 h.
Study design
Initial optimization of test conditions was conducted in Centre 1 using 40
echinocandin WT and 4 molecularly characterized non-WT Aspergillus spp.
strains. Subsequently, pre-weighed pure antifungals and chemical reagents
as well as all previously tested Aspergillus spp. isolates were sent blinded to
Centre 2 and Centre 3, accompanied by step-by-step instructions for the
evaluation of the methods’ performance in a three-laboratory multicentre
setting (Greece, Denmark and the Netherlands). All Aspergillus spp. isolates
were tested in three centres by experienced mycologists with all four
methods (macroscopic, microscopic, spectrophotometric and colorimetric)
following the optimized conditions. In each participating laboratory all
plates were read by an experienced reader, blinded to the susceptibility
phenotype of the strains.
Microscopic method
The MEC was defined as the lowest echinocandin concentration at
which short, stubby and highly branched hyphal clusters were observed,
using an inverted microscope, compared with the growth control well after
24 and 48 h of incubation.
Macroscopic method
Fungal growth (FG) in each well was determined by macroscopic inspection
of the plate after 24 and 48 h of incubation, with the aid of a magnifying
mirror, and the MIC was defined with five endpoints as the highest
drug concentration with no growth (score 0), slight growth (75% growth
inhibition, score 1), prominent reduction of growth (50% growth inhib-
ition, score 2), slight reduction of growth (25% growth inhibition, score 3)
and no inhibition of growth (score 4) compared with growth of the drug-
free control.
Spectrophotometric method
The OD of each well was measured spectrophotometrically at 405 nm as at
this wavelength hyphae have the highest OD21 at either a single point
(centre of the well) or 10 points across the horizontal dimension after 24
and 48 h of incubation and the percentage of FG (%FG) was calculated for
each well as %FG = (ODdrug well#ODbackground drug well)/(ODdrug-free
well#ODbackground drug-free well)%100. The spectrophotometric MICs were
determined as the lowest drug concentrations corresponding to different
percentage of growth inhibition (100%#%FG) compared with the drug-free
control.
Colorimetric method
Preliminary studies were carried out in order to determine the optimal con-
centrations of XTT/MEN and incubation period that produced a well-defined
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concentration–effect curve with a decline in MA observed at the MEC. In
particular, different concentrations of XTT (100, 200, 400 and 600 mg/L)
and MEN (1.25, 6.25, 12.5 and 25lM) were used in plates incubated for 24
and 48 h. The absorbance (ABS) at 450/630 nm was measured after 1–5 h
of incubation with 50lL of XTT/MEN solution (5%) in each well. The %MA
assessed by %XTT conversion was calculated for each well as %MA =
(ABSdrug well#ABSbackground drug well)/(ABSdrug-free well#ABSbackground drug-free
well)%100. The colorimetric MICs were determined as the lowest drug con-
centrations corresponding to different percentage of inhibition of MA
(100%#%MA) compared with the drug-free control.
Inter-experimental variation was evaluated by testing selected isolates
of each species (27–32 isolates, 5–10 isolates/species). Experiments were
performed independently on two different days under the same conditions
with individually prepared inocula. In addition, stability of XTT solution
stored at 4C and #70C either alone or with MEN was assessed with
selected isolates of each species up to 6 months. Parameters that could
potentially affect the performance of the XTT-based assay [once- or twice-
subcultured isolates, with or without filtration of the inoculum, adjustment
of the suspension by counting the conidia in a haemocytometer chamber
or by using a spectrophotometer, RPMI 1640 medium provided by different
manufacturers (AppliChem versus Sigma–Aldrich) and incubation tempera-
ture of 35C versus 37C] were evaluated with selected isolates of each
species.
Analysis
MIC endpoints were compared with MECs between WT and non-WT
A. fumigatus isolates in order to find the best MIC endpoint and method
that separated the two groups. The inter-method essential agreement (EA)
between the reference microscopic MEC method and the macroscopic,
spectrophotometric and colorimetric MIC methods was calculated for each
echinocandin and species as the percentage of isolates with MICs within
one 2-fold dilution of the microscopic MEC for all three participating centres.
The inter-centre EA of each method was calculated for each echinocandin
and species as the percentage of isolates with microscopic MEC and macro-
scopic, spectrophotometric and colorimetric MICs within one 2-fold dilution
of the median (among the three centres) MEC and MICs, respectively.
The differences between the inter-centre EA of the reference microscopic
MEC method and the macroscopic, spectrophotometric and colorimetric
MIC methods was assessed with paired t-test for all echinocandins (P< 0.05
was considered statistically significant). Categorical agreement (CA) in dis-
tinguishing non-WT from WT A. fumigatus SC isolates was calculated for all
centres and each echinocandin. The inter-centre variation of the method
with the highest inter-centre EA and CA was estimated by calculating
the sum of the absolute log2 differences between the MIC of each centre
and the median MIC and compared with the inter-centre variation of the
microscopic MEC determination.
Results
Microscopic method
The determination of MECs with the inverted microscope was
quite challenging since the differences by microscopy were sub-
tle (Figure 1). In particular, no clear echinocandin-induced mor-
phological hyphal alterations could be defined with the
exception of A. flavus SC isolates. For the other species, MEC val-
ues were reported as the lowest concentration where differences
in the hyphal density were observed. For the WT isolates, the me-
dian (range) MECs were 0.016 (0.001–0.125), 0.5 (0.125–1) and
0.03 (0.002–0.125) mg/L (Centre 1), 0.03 (0.016–0.125), 0.25
(0.06–0.5) and 0.03 (0.008–0.125) mg/L (Centre 2) and 0.008
(0.004–0.016), 0.125 (0.125–0.25) and 0.016 (0.004–0.03) mg/L
(Centre 3) for anidulafungin, caspofungin and micafungin, respect-
ively. The distributions of MECs for anidulafungin (0.001–0.125 mg/L)
and micafungin (0.002–0.125 mg/L) spanned seven–eight 2-fold
dilutions and were wider than those of caspofungin (0.06–1 mg/L,
five 2-fold dilutions) mainly because among the four species, A. ter-
reus SC had the lowest MECs for anidulafungin (0.001–0.06 mg/L)
and micafungin (0.002–0.06 mg/L). All non-WT isolates had high
MECs (>1 mg/L) for all echinocandins. The overall EA between the
centres was 72% for anidulafungin, 88% for caspofungin and 83%
for micafungin (Table 1). Of note, although the most significant
echinocandin-induced morphological changes were found forA. fla-
vus SC, the highest MEC discrepancies were also observed for this
species, emphasizing the inter-laboratory variability and unsatisfac-
tory reproducibility of the method. The CA in distinguishing WT from
non-WT A. fumigatus SC isolates was 100% for all three echinocan-
dins and centres (Table 1). The MIC values of anidulafungin and
micafungin for the quality control isolates were within the reference
ranges.
Macroscopic method
Macroscopic evaluation of growth in each well mostly resulted in
growth scores ranging from 3 at high concentrations to 4 at low
concentrations of all echinocandins (Figure 2). Growth scores
down to 1 were also found for some isolates, particularly of
A. niger. Notably, for some WT isolates no decrease in turbidity was
observed at any concentration, whereas slight growth inhibition
(score 3) was found for some non-WT isolates at low concentra-
tions, indicating that macroscopic assessment is not reliable for
echinocandin susceptibility testing of Aspergillus spp. The highest
agreement for macroscopic MICs was found with score 3 (slight
growth inhibition) for all echinocandins. In particular, the levels of
agreement between the microscopic and macroscopic (score 3)
methods for all centres was 26% for anidulafungin (54% in Centre
1, 13% in Centre 2 and 13% in Centre 3), 54% for caspofungin
(73% in Centre 1, 30% in Centre 2 and 58% in Centre 3) and 29%
for micafungin (54% in Centre 1, 10% in Centre 2 and 23% in
Centre 3) (Table 1). The overall inter-centre EA was 53% for anidu-
lafungin, 58% for caspofungin and 58% for micafungin (Table 1)
and it was significantly lower than the microscopic MEC determin-
ation for all echinocandins (t-test P= 0.0002). The average CA in
distinguishing WT from non-WT A. fumigatus SC isolates was 78%,
82% and 88% for anidulafungin, caspofungin and micafungin
(range 63%–100% among centres), respectively, as several WT
strains were misclassified as non-WT (Table 1).
Spectrophotometric method
The median (range) OD increase of drug-free control after 24/48 h
of incubation was low: 0.17 (0.08–0.53)/0.30 (0.15–0.42) for
Centre 1, 0.09 (0.03–0.19)/0.22 (0.12–0.37) for Centre 2 and 0.04
(0–0.11)/0.13 (0.04–0.26) for Centre 3. The single- and multi-point
spectrophotometric readings of the wells did not produce a clear-
cut endpoint since the percentage of growth inhibition compared
with the drug-free control ranged from 0% to 50% for most
WT and non-WT isolates, making distinguishing between them im-
possible (Figure 3). Using different cut-offs of growth inhibition
(10%–50%), the levels of agreement between the microscopic
and spectrophotometric methods and between the centres never
XTT assay for MEC determination of Aspergillus spp. JAC
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exceeded 20% and in most cases ranged between 5% and 10%,
indicating that the spectrophotometric assessment of growth
does not reflect the microscopic changes caused by echinocan-
dins. In particular, the highest agreement for spectrophotometric
MICs was found using the 50% cut-off growth inhibition. The levels
of agreement between the microscopic and spectrophotometric
(50% growth inhibition) methods for all centres were: 7% for ani-
dulafungin (12% in Centre 1, 3% in Centre 2 and 5% in Centre 3),
12% for caspofungin (10% in Centre 1, 13% in Centre 2 and 15% in
Centre 3) and 6% for micafungin (12% in Centre 1, 3% in Centre 2
and 3% in Centre 3) (Table 1). The overall EA between the centres
was 61% for anidulafungin, 66% for caspofungin and 66% for
micafungin (Table 1) and was significantly lower than for the
microscopic MEC determination for all echinocandins (t-test
P= 0.0067). The average CA in distinguishing WT from non-WT A.
fumigatus SC isolates was 44%, 41% and 42% for anidulafungin,
caspofungin and micafungin (range 14%–85% among centres),
respectively, since a number of WT strains were wrongly classified
as non-WT and vice versa (Table 1).
Colorimetric method
The combination of 400 mg/L XTT and 6.25lM MEN was found to
be optimal in distinguishing WT from non-WT isolates in pilot stud-
ies (data not shown) and was further evaluated in all three centres
with incubation of 1, 2 and 3 h with XTT/MEN solution. Colour
production in the drug-free control reached a median (range)
ABS450/630 after 1 h and 2 h of 1.61 (0.64–2.80) and >3.00 (1.70 to
>3.00) in Centre 1, 0.41 (0.08–1.02) and 1.13 (0.23–2.27) in Centre
2 and 0.55 (0.16–1.24) and 1.51 (0.63–3.6) in Centre 3. Further in-
cubation to 3 h did not increase XTT conversion. Notably, significant
inter-strain and inter-centre variation in colour production was
found. However, all non-WT isolates converted XTT, even at high
concentrations of echinocandins, resulting in <50% colour
Figure 1. Microscopy images at concentrations of echinocandins adjacent to the MEC (one dilution higher) against the WT Aspergillus spp. isolates
(8 mg/L for the non-WT isolate).
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inhibition at the highest echinocandin concentration in all three
centres (Figures 2 and 3). In contrast, prominent inhibition of col-
our production was observed at the lower concentrations of all
echinocandins for the WT isolates (Figures 2 and 3). The colour in-
hibition endpoints for optimal EA between the microscopic MECs
and the colorimetric MICs differed considerably among species,
drugs and centres. Overall for all centres, the best EA between
microscopic MECs and colorimetric MICs was found with the 50%
colour inhibition endpoint (43% for anidulafungin, 69% for caspo-
fungin and 37% for micafungin) although variable levels of EA
among the species were found (25%–60% for anidulafungin,
52%–83% for caspofungin and 17%–58% for micafungin)
(Table 1).
Since microscopic MEC determination may be subjective and
questionable as a gold standard, the overall agreement among
XTT MICs of the three centres using different cut-off levels of
inhibition of MA for each species and echinocandin was calculated.
The 50% inhibition of XTT conversion yielded the highest EA among
the three centres for all species providing that an ABSdrug-free control
of >0.8 was obtained, i.e. 1 h for Centre 1 and 2 h for Centre 2 and
Centre 3 (Figure 3). For anidulafungin, although the 50% inhibition
of XTT conversion cut-off resulted in 10% lower inter-centre
Table 1. Overall levels of inter-centre/inter-method EA (within one 2-fold dilution) and CA of the reference (microscopically defined MECs), macro-
scopic (based on score 3; 25% growth inhibition), spectrophotometric (based on 50% growth inhibition) and colorimetric (based on 50% inhibition
of XTT conversion) methods for Aspergillus spp.
Species No. of isolates Antifungal
Inter-centre/inter-methoda EA (CA), %
microscopic macroscopic spectrophotometric colorimetric
A. fumigatus SC 14 AFG 83/REF (100) 50/9 (78) 57/0 (44) 90/25 (100)
CAS 87/REF (100) 57/48 (82) 77/7 (41) 90/72 (100)
MFG 100/REF (100) 60/12 (88) 60/3 (42) 100/29 (100)
A. flavus SC 10 AFG 60/REF 53/33 67/3 73b/34
CAS 87/REF 47/50 70/17 93/68
MFG 77/REF 60/53 80/3 80/17
A. terreus SC 10 AFG 53/REF 53/30 60/17 70b/53
CAS 90/REF 50/37 60/13 90/52
MFG 63/REF 60/17 63/7 83/58
A. niger SC 10 AFG 90/REF 57/33 60/7 77b/60
CAS 87/REF 77/80 57/13 97/83
MFG 90/REF 53/33 60/10 73c/44
Total 44 AFG 72/REF 53/26 61/7 72/43
CAS 88/REF 58/54 66/12 89/69
MFG 83/REF 58/29 66/6 78/37
AFG, anidulafungin; CAS, caspofungin; MFG, micafungin.
aThe percentage EA between MICs of each method compared with the reference (REF) microscopic MECs was determined.
bHigher inter-centre EA (87% for A. flavus and A. terreus and 83% for A. niger) was found with 40% inhibition of XTT conversion.
cHigher inter-centre EA (87%) was found with 60% inhibition of XTT conversion.
AFG
WT A. fumigatus SC
non-WT A. fumigatus SC
CAS
MFG
AFG
CAS
MFG
Figure 2. Macroscopic evaluation of growth (left) and XTT conversion (right) by a WT A. fumigatus SC (top) and a non-WT A. fumigatus (bottom) iso-
late, respectively, in the presence of different concentrations of anidulafungin (AFG) and micafungin (MFG) ranging from (left to right) 1 to 0.001 mg/L
and caspofungin (CAS) ranging from 4 to 0.004 mg/L. The last column represents the drug-free growth control. This figure appears in colour in the
online version of JAC and in black and white in the print version of JAC.
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agreement than the 40% inhibition of XTT conversion cut-off (72%
versus 82%, respectively) overall for all species, for A. fumigatus
the 50% cut-off yielded higher levels of agreement than the 40%
cut-off (90% versus 87%, respectively). Since most clinical isolates
are A. fumigatus and since acquired echinocandin resistance has
not yet been reported in non-A. fumigatus species to our know-
ledge, we propose the 50% XTT conversion inhibition cut-off for all
echinocandins.
The median XTT MIC50 endpoints of anidulafungin (0.002–
0.004 mg/L), caspofungin (0.125–0.5 mg/L) and micafungin
(0.004–0.008 mg/L) for the WT A. fumigatus isolates and of caspo-
fungin for all the other species (0.125–0.5 mg/L) were similar
across the centres. For the non-A. fumigatus species, the anidula-
fungin and micafungin median XTT MIC50s determined at Centre 2
(0.016 and 0.03 mg/L, respectively) were two–three 2-fold dilu-
tions higher than in Centre 1 and Centre 3 (0.002 and 0.004–
0.008 mg/L, respectively). All non-WT isolates had high colorimet-
ric MICs (>1 mg/L) in all three centres. Excellent EA (100%) was
found for the non-WT A. fumigatus isolates, while the overall inter-
centre EA for all isolates was 72% for anidulafungin, 89% for
caspofungin and 78% for micafungin (Table 1). No statistically
significant differences with the microscopic MEC determination
were found for any of the echinocandins (t-test P = 0.22). The CA
in distinguishing WT from non-WT A. fumigatus SC isolates was
100% for all three echinocandins and centres (Table 1). The
inter-centre variability of the colorimetric method was 42%–
47% lower than the inter-centre variability of the microscopic
method (58, 43 and 53 versus 109, 74 and 92 sum of absolute
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Figure 3. Spectrophotometric (a) and colorimetric (b) concentration–effect curves for the three echinocandins based on the OD at 405 nm and the
ABS after XTT conversion by viable fungi measured at 450/630 nm (400 mg/L XTT/6.25lM MEN, incubation 1–2 h until drug-free control reached an
ABS >0.8), respectively.
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log2 differences for anidulafungin, caspofungin and micafungin
for the two methods, respectively).
Two centres (1 and 3) repeated XTT experiments for 27–32
(5–10 isolates/species) isolates and reproducibility was 70%–90%.
The EA between 1 h and 2 h XTT endpoints was 87% for caspofun-
gin and 78%–93% for anidulafungin and micafungin.
When the XTT solution was stored at 4C, either alone or with
MEN, a 50% loss of efficacy was observed at Day 15, whereas it was
stable for up to 6 months at #70C. The performance of the colori-
metric method was not influenced (zero#one 2-fold dilution differ-
ences) by any of the parameters tested (once- or twice-subcultured
isolates, filtration of the inoculum, adjustment of the suspension by
haemocytometer chamber or spectrophotometer, RPMI 1640 me-
dium provider or incubation temperature of 35C or 37C).
Discussion
Although correct discrimination between echinocandin WT and
non-WT A. fumigatus was obtained using the gold standard BMD
EUCAST E.Def. 9.3.1 method with microscopic endpoint reading as
recommended, this method is difficult to read and implement in
the routine laboratory. Consequently, echinocandin susceptibility
testing of Aspergillus isolates either is not performed or is only con-
ducted in reference centres. The present multicentre study con-
firmed that the standard microscopic MEC determination of
EUCAST E.Def. 9.3.1 is quite challenging, yielding considerable
inter-centre variation even for experienced mycologists. We more-
over showed that both macroscopic and spectrophotometric end-
point readings of EUCAST E.Def. 9.3.1 plates showed poor overall
inter-centre EA (53%–66%) with significant differences compared
with the microscopic MEC determination for all echinocandins, as
well as low CA (41%–88%) in distinguishing WT from non-WT
isolates, and thus are not valid alternative methods for MEC deter-
mination. Taking into account the potential for increased objectiv-
ity, a colorimetric XTT assay for echinocandin susceptibility testing
of Aspergillus spp. was developed and validated. The optimal test
conditions were 400 mg/L XTT/6.25lM MEN and incubation until
an ABS at 450/630 nm of >0.8 of drug-free control was reached.
The colorimetric method could easily detect non-WT isolates since
these resulted in <50% inhibition of XTT conversion compared
with the drug-free control at high concentrations of all three
echinocandins. High inter-centre CA (100%) and EA (>70% for all
species, >90% for A. fumigatus SC) was found among XTT MICs
thus reducing inter-centre MIC variation by 42%–47%.
CLSI and EUCAST echinocandin susceptibility testing methods
for Aspergillus spp. are based on broth dilution and are technically
demanding, which is reflected in the variability of published MEC
ranges.14–16 Notably, they may not reliably identify non-WT iso-
lates, as was demonstrated in a study for a multi-azole-resistant
A. fumigatus isolate from a patient failing itraconazole and caspo-
fungin therapy.7 That isolate was found to be echinocandin WT by
CLSI and EUCAST BMD methods, but non-WT by Etest and in vivo
in a haematogenous mouse model. Reduced susceptibility was
linked to fks gene up-regulation and no fks mutations were found.
Obviously, this raises great concern if the current reference meth-
odology clearly and reliably separates isolates with resistance
mechanisms from isolates without. With the increasing number of
reports on azole resistance in Aspergillus spp., the echinocandin
class of drug becomes increasingly important and more often
used (as salvage or combination therapy)—a scenario where reli-
able susceptibility testing is of utmost importance.
For the EUCAST methodology specifically, where a high inocu-
lum of 105 cfu/mL is used (as compared with the CLSI method) the
determination of MEC of echinocandins is particularly challenging
because of heavy growth after 48 h. It is difficult to identify short
aberrant mycelia in drug-containing wells when growth is more or
less confluent. Subtle differences of growth between wells with dif-
ferent concentrations of echinocandins cannot be detected macro-
scopically or microscopically even when multiple reading points per
well were used. Despite these subtle differences in growth, signifi-
cant differences (>50%) in metabolism in drug-free and drug-
containing wells were detected with the XTT method after 24 h of
incubation. No XTT conversion was observed at echinocandin con-
centrations within the MIC ranges of WT isolates, facilitating the de-
tection of non-WT strains with an objective, fast and automated
method. The XTT method could also differentiate WT isolates with
different MECs in a reproducible manner among different laborato-
ries provided that drug-free controls attained sufficient MA
(ABS > 0.8) within 1–2 h of incubation with XTT. The XTT/MEN ‘ready
to use’ solution could be stored at #70C to increase stability and
used after MEC was determined with the standard approach in the
EUCAST plate. Furthermore, inter-laboratory agreement may be
increased further when a standardized inoculum is used either via
filtration (as used in Centre 3) or via microscopic observation and
counting in a haemocytometer (as used in Centre 1).
This study has strengths and limitations. The strengths are that
the study was performed in laboratories with mycology expertise
and that the same plates were used for macroscopic, spectro-
photometric and colorimetric endpoints, thus avoiding differences
in inoculum or viability of the inoculum to affect intra-centre
comparisons. The major limitation is that non-WT isolates with
more modest resistance were not available and hence the CA may
be overestimated (possibly particularly so for the methods with
subjective endpoint reading).
In summary, to be of any value, an in vitro susceptibility test
must be reproducible and able to detect resistance. The echino-
candin XTT assay for Aspergillus spp. developed in the present
study is quite simple and it avoids the need for special training or
expertise associated with the macroscopic/microscopic endpoint
reading for the reference BMD method. Indeed, calculation of the
%MA can be performed automatically through a predefined proto-
col in a plate-reading spectrophotometer, allowing an objective
determination of the XTT MIC using the proposed cut-off values
of inhibition of XTT conversion.
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